Airsculpt Technologies, Inc. · NASDAQ:AIRS
Airsculpt Technologies — Q1 2025 Earnings Presentation
17 slides from Airsculpt Technologies's earnings presentation, May 2, 2025
Slide 1: Investor Presentation
Investor Presentation May 2025
Slide 2: Yogi Jashnani and Dennis Dean
Yogi Jashnani Dennis Dean CHIEF EXECUTIVE OFFICER CHIEF FINANCIAL OFFICER 28
Slide 3: AirSculpt Snapshot
2012 AirSculpt Snapshot FOUNDING YEAR A disruptor in the Body Contouring marketplace Large Addressable market with 32 efficacious procedures performed NUMBER OF CENTERS by expert surgeons across 31 centers in North America and 1 location in the United Kingdom Significant white space opportunity at s
Slide 4: Why We Win
WHY WE WIN • Uniquely efficacious patented method with a proven track record of performing body contouring procedures • Achieved critical mass with significant runway for growth • Strong return on investment with positive cash flow generation across U.S. centers • Incentivized management team with d
Slide 5: What is AirSculpt? How is It Different?
What is AirSculpt®? How is it Different? AirSculpt is a fast-growing global provider of Minimally invasive procedure delivered in one body sculpting procedures delivering a session – no scalpel, stiches or general premium consumer experience anesthesia Dramatic, fast, natural-looking results – can p
Slide 6: Body Contouring Offerings
Body Contouring Offerings AirSculpt has a broad offering of innovative procedures AirSculpt is the largest fat transfer provider in the industry Fat Transfer ~20% of procedures include a fat transfer Areas include buttocks, breast, hip, and hand AirSculpt+ Enhanced skin tightening using Apyx Medical
Slide 7: How We Do It
How We Do It Access to elite surgeons 31 centers in North America Generate leads through multiple 3rd party credit providers each deliver positive cash flow platforms including social allow for ease of payment for marketing, celebrity patients endorsements, and patient testimonials1 (1) Includes pai
Slide 8: AirSculpt's Attractive Business Model
AirSculpt’s Attractive Business Model • Centers are located primarily in metropolitan cities near high end retail environments with consistent patient traffic • Consistent technology innovation cycle has supported average revenue per case in the $12,000-$13,000 range • De novo centers have relativel
Slide 9: Focused De Novo Growth Story
Focused De Novo Growth Story Center Opening Takes ~12 months Physician Market Research Design & Build Center Recruitment & Customer Acquisition Open Center Training Recent Openings Overland Park, KS July 2024 Columbus, OH August 2024 Deerfield, IL September 2024 Birmingham, MI September 2024 White P
Slide 10: Historical Performance
Historical Performance $250 Total Revenue ($MM) $50 Adj. EBITDA ($MM) 43 196 39 $200 180 $40 45 169 $150 133 $30 21 $100 $20 17 63 $50 41 $10 7 $0 $0 2019 2020 2021 2022 2023 2024 2019 2020 2021 2022 2023 2024 Revenue Adj. 10.7 10.7 12.1 12.9 13.1 12.8 16.8% 26.5% 33.4% 23.0% 22.1% 11.5% Per Case EB
Slide 11: Large Potential White Space Opportunity
Large Potential White Space Opportunity AirSculpt Has Significant White Space Opportunity +350 – 550 +150 – 250 International Centers +200 – 300 32 U.S. / Canada Centers Current Potential Additional De Novo Center Opportunities White Space Strong demand for body sculpting services nationwide ensures
Slide 12: Business Priorities
Business Priorities In order to deliver consistent revenue growth while maintaining industry leading EBITDA margins, AirSculpt is focused on: Culture Revenue Creating a culture that is aligned on one vision with a Improving our go to market singular voice across all aspects strategy of our enterpris
Slide 13: AirSculpt Business Priorities
Vision as New Leadership takes Helm - AirSculpt Now and Going Forward AirSculpt Business Priorities 1 Marketing 2 Sales Processes 3 Product and sales innovation Modernizing and applying a Implementing best returns based spend model practices in recruitment, Executing actions that drive on a national
Slide 14: 2025 Outlook
FY2025 Outlook 2025 Outlook • Revenue of approximately $160 million to $170 • Adjusted EBITDA of approximately $16 to $18 million 7.2% 14
Slide 15: Quote from Dr. Aaron Rollins
“Our positive performance record, the proprietary technology we possess, and the large addressable market with which we operate in provides us with a vast opportunity from which to grow.” - Dr. Aaron Rollins, Founder & Exective Chairman, AirSculpt 15
Slide 16: Appendix - Financial Highlights
- Appendix - FINANCIAL HIGHLIGHTS 16
Slide 17: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation Three Months Ended March 31, 2025 2024 Net (loss)/income $ (2,847) $ 6,029 Plus Equity-based compensation(1) 1,239 (6,781) Restructuring and related severance costs 863 296 Depreciation and amortization 3,242 2,805 Loss on disposal of long-lived assets - 5 Interest exp
AirSculpt Technologies — Q1 2025 Earnings Presentation on 6ix